Latest Vietnam News

The a2 Milk Company posted a 12.4% rise in FY26 revenue to NZ$1.975 billion, but net profit from continuing operations fell 5.8% amid supply chain disruptions in China. The company declared a $300 million special dividend and expects mid single-digit revenue growth in FY27.

Sparc Technologies has secured commercial traction for its graphene additive ecosparc® with major coatings players AkzoNobel and Petro Vietnam Paint, launched a new additive range for electrostatic coatings, and marked six months of continuous operation at its green hydrogen pilot plant.

OMG Group delivered a near 50% jump in FY26 net sales, expanding its product range nationally and breaking into international markets with new distribution agreements.

EVZ Limited closed FY26 with a net positive operating cash flow of $10.1 million and an $18.3 million cash balance, while maintaining a robust $80 million contract backlog and progressing several acquisition opportunities for FY27.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

Recce Pharmaceuticals has expanded its intellectual property footprint with a key patent granted in Vietnam for its RECCE® anti-infective drugs, reinforcing its presence in a critical Southeast Asian market grappling with high antibiotic resistance.

Critica Limited’s recent drilling at its Jupiter Rare Earth Project has validated broad, near-surface high-grade zones, underpinning an imminent resource upgrade and advancing its scoping study.

Fluence Corporation has secured two seawater desalination contracts in Vietnam worth approximately US $3.7 million. The projects, set for completion by year-end 2026, will produce up to 7,500 cubic metres of potable water daily on Phu Quoc Island, addressing critical water scarcity.

TruScreen Group posted a NZ$2.25 million loss for FY2026, with its auditor highlighting material uncertainty over the company’s ability to continue without further funding. Revenue rose to NZ$2.4 million amid geographic expansion, but cash burn and accumulated losses remain significant.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.

TruScreen has secured clinical validation from the world’s largest cervical screening study in China, setting the stage for rapid market expansion across Asia, Africa, and Europe.

Sparc Technologies secures its first international commercial partner as Petro Vietnam Paint commits to using ecosparc® in its PERAPHENE coatings range, targeting highly corrosive environments with improved anticorrosion performance.